🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

76,26 EUR

Máx. histórico

110,88

543 días

Caída desde máximo

-31,22%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,01%

Cierre anterior

76,27

Rango de hoy

75,90 – 76,65

Volumen hoy

1.490.914

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,54 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 1 día
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,40%
Fecha de pago Importe por participación
05/05/2026 4,1200 EUR
12/05/2025 3,9200 EUR
13/05/2024 3,7600 EUR
30/05/2023 3,5600 EUR
06/05/2022 3,3300 EUR
05/05/2021 3,2000 EUR
04/05/2020 3,1500 EUR
09/05/2019 3,0700 EUR
11/05/2018 3,0300 EUR
16/05/2017 2,9600 EUR
10/05/2016 2,9300 EUR
11/05/2015 2,8500 EUR
12/05/2014 2,8000 EUR
09/05/2013 2,7700 EUR
10/05/2012 2,6500 EUR
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/03/2001 55,20 56,19 54,10 56,19 +0,89% 3,78% 1.093.298
14/03/2001 55,70 55,70 55,70 55,70 +0,00% 0,00% 0
13/03/2001 55,05 55,84 54,40 55,70 -0,44% 2,62% 1.931.468
12/03/2001 55,84 56,29 54,95 55,94 -0,18% 2,40% 1.284.242
09/03/2001 56,44 56,89 55,94 56,04 -1,23% 1,67% 2.028.547
08/03/2001 59,67 59,67 56,39 56,74 -5,55% 5,50% 1.964.828
07/03/2001 58,83 60,17 57,88 60,07 +1,60% 3,89% 1.115.224
06/03/2001 61,36 61,36 58,43 59,13 -1,74% 4,78% 2.024.688
05/03/2001 59,48 61,56 59,18 60,17 +1,68% 4,01% 1.346.023
02/03/2001 57,64 60,02 57,39 59,18 +3,48% 4,57% 4.372.678
01/03/2001 58,68 60,37 57,19 57,19 -2,54% 5,42% 10.740.788
28/02/2001 60,57 60,67 57,78 58,68 -2,48% 4,76% 1.647.143
27/02/2001 60,77 61,32 59,43 60,17 -1,87% 3,11% 1.866.773
26/02/2001 60,72 61,32 58,78 61,32 +2,66% 4,18% 9.119.846
23/02/2001 62,01 62,66 59,52 59,72 -4,68% 5,05% 1.742.924
22/02/2001 62,81 63,40 60,87 62,66 -0,79% 4,04% 1.540.931
21/02/2001 62,66 63,95 62,66 63,16 +1,03% 2,06% 1.592.399
20/02/2001 64,65 65,34 61,66 62,51 -1,57% 5,69% 1.902.548
19/02/2001 62,41 64,05 62,41 63,50 +1,19% 2,63% 961.741
16/02/2001 63,06 64,15 62,76 62,76 -0,32% 2,21% 1.439.096
15/02/2001 63,65 63,65 62,56 62,96 -1,71% 1,72% 1.438.067
14/02/2001 64,15 64,45 63,75 64,05 -0,31% 1,09% 1.605.752
13/02/2001 64,15 64,65 63,65 64,25 +0,94% 1,55% 1.345.557
12/02/2001 63,06 64,05 62,26 63,65 +1,59% 2,84% 1.389.240
09/02/2001 62,86 63,35 61,86 62,66 -0,32% 2,37% 892.872
08/02/2001 62,06 63,25 61,32 62,86 +1,94% 3,12% 1.143.696
07/02/2001 61,66 61,66 60,72 61,66 +0,24% 1,53% 1.288.567
06/02/2001 60,67 61,66 59,77 61,51 +1,39% 3,11% 1.237.449
05/02/2001 59,08 60,67 57,88 60,67 +3,48% 4,71% 2.066.985
02/02/2001 60,17 60,17 58,28 58,63 -1,75% 3,14% 1.378.958